trial · primary record
Dexamethasone Sodium Phosphate Injection 20 mg
Ureteral Stent-Related Symptom
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 70 |
| Primary completion | 2027-04 |
| Primary endpoint | Global Quality of Life Score of Ureteral Stent Symptom Questionnaire (USSQ) |
| Registry ID | NCT06930690 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:40:33.471Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06930690
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.